MREO · Mereo BioPharma Group plc · Documents
Market Cap
$47.12M
Shares
159.69M
Volume · Oct 21
62.64K
Avg daily vol (3M)
4M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2023-06-30 | — | |
| 6-K | — | 2023-06-07 | — | |
| 6-K | — | 2023-06-05 | — | |
| 6-K | — | 2023-05-22 | — | |
| 6-K | — | 2023-05-08 | — | |
| 6-K | — | 2023-05-05 | — | |
| 6-K | — | 2023-04-27 | — | |
| 6-K | — | 2023-04-12 | — | |
| 20-F | — | 2023-03-28 | 2022-12-31 | |
| 6-K | — | 2023-03-28 | — | |
| 6-K | — | 2023-03-21 | — | |
| 6-K | — | 2022-11-10 | — | |
| 6-K | — | 2022-11-10 | — | |
| 6-K | — | 2022-11-02 | — | |
| 6-K | — | 2022-11-02 | 2022-06-30 | |
| 6-K | — | 2022-10-28 | — | |
| 6-K | — | 2022-10-21 | — | |
| 6-K | — | 2022-10-18 | — | |
| 6-K | — | 2022-10-17 | — | |
| 6-K | — | 2022-10-04 | 2022-10-03 | |
| 6-K | — | 2022-09-26 | — | |
| 6-K | — | 2022-09-12 | — | |
| 6-K | — | 2022-08-31 | — | |
| 6-K | — | 2022-08-22 | — | |
| 6-K | — | 2022-07-05 | — | |
| 6-K | — | 2022-06-02 | — | |
| 6-K | — | 2022-05-26 | — | |
| 6-K | — | 2022-05-26 | — | |
| 6-K | — | 2022-05-25 | — | |
| 6-K | — | 2022-05-17 | — | |
| 6-K | — | 2022-05-17 | — | |
| 6-K | — | 2022-05-09 | — | |
| 6-K | — | 2022-05-09 | — | |
| 20-F | — | 2022-03-31 | 2021-12-31 | |
| 6-K | — | 2022-03-31 | — | |
| 6-K | — | 2022-03-14 | — | |
| 6-K | — | 2022-03-01 | — | |
| 6-K | — | 2021-12-22 | — | |
| 6-K | — | 2021-11-30 | — | |
| 6-K | — | 2021-11-04 | — | |
| 6-K | — | 2021-11-02 | 2021-06-30 | |
| 6-K | — | 2021-10-26 | — | |
| 6-K | — | 2021-10-26 | — | |
| 6-K | — | 2021-10-01 | — | |
| 6-K | — | 2021-09-20 | — | |
| 6-K | — | 2021-07-20 | — | |
| 6-K | — | 2021-06-02 | — | |
| 6-K | — | 2021-05-28 | — | |
| 6-K | — | 2021-04-30 | — | |
| 6-K | — | 2021-04-16 | — |
Showing 51–100 of 140 filings